Loading…
Kestra Medical Technologies, Ltd. is projected to rise to $24.04 by 2027, a +14% move from its current price of $21.00. KMTS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $20.28 | $21.00 | $21.76 | +0.02% |
| May 30 | $19.99 | $21.01 | $22.08 | +0.05% |
| May 31 | $19.77 | $21.01 | $22.34 | +0.07% |
| Jun 1 | $19.59 | $21.02 | $22.55 | +0.09% |
| Jun 2 | $19.43 | $21.02 | $22.75 | +0.12% |
| Jun 3 | $19.29 | $21.03 | $22.92 | +0.14% |
| Jun 4 | $19.16 | $21.03 | $23.09 | +0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $19.16 | $21.03 | $23.09 | +0.16% |
| Week 2 | $18.47 | $21.07 | $24.03 | +0.32% |
| Week 3 | $17.96 | $21.10 | $24.79 | +0.49% |
| Week 4 | $17.54 | $21.14 | $25.46 | +0.65% |
| Week 5 | $17.19 | $21.17 | $26.07 | +0.81% |
| Week 6 | $16.88 | $21.20 | $26.64 | +0.97% |
| Week 7 | $16.60 | $21.24 | $27.17 | +1.14% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.
The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes.
The company was founded in 2014 and is based in Kirkland, Washington.
Kestra Medical Technologies, Ltd. (KMTS) is a healthcare company. The current price is $21.64 per share, and the market cap is $1.26B. It is ranked #2354 by market capitalization.
The stock’s technical context shows the 50-day simple moving average (SMA50) at $20.58 and the 200-day simple moving average (SMA200) at $22.95, with a support level at $18.76 and a resistance level at $23.81.
The 30-day trading range is $17.02 to $27.52, and annualized volatility is 70%. The forecast for 2026 shows an average price of $21.64 with a min of $17.87 and a max of $32.44, and a neutral sentiment (ROI 0). Over the longer horizon, the forecast depicts a bullish trajectory, with higher averages and ROIs in later years (e.g., 2030 avg $40.68; 2040 avg $86.64; 2050 avg $207.72) and corresponding max values (e.g., 2030 max $66.09; 2040 max $172.18; 2050 max $464.00).
A major floor 18.4% below — a decisive break under it would weaken the trend.
The nearest floor, 7.1% below — buyers have tended to step in here.
The nearest ceiling, 13.4% above — a clean break opens room to run.
A major ceiling 32.6% above — clearing it would confirm fresh momentum.
Key KMTS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KMTS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $21.36 | Sell | $21.22 | Sell |
| MA 10 | $20.95 | Buy | $21.12 | Sell |
| MA 20 | $20.95 | Buy | $21.09 | Sell |
| MA 50 | $20.67 | Buy | $21.36 | Sell |
| MA 100 | $22.53 | Sell | $22.05 | Sell |
| MA 200 | $23.02 | Sell | $22.37 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.45 | Neutral |
| Stoch RSI (14) | 58.27 | Neutral |
| CCI (20) | 4.67 | Neutral |
| Williams %R (14) | -43.15 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | -0.24 | Sell |
| Bollinger %B (20,2) | 0.52 | Neutral |
| Stochastic %K (14) | 56.85 | Neutral |
| TRIX (15) | 0.00 | Buy |
| Awesome (5,34) | 0.25 | Buy |
| Ultimate (7,14,28) | 60.96 | Neutral |
| Momentum (10) | -0.57 | Sell |
| Aroon Osc (25) | -20.00 | Sell |
| Hull MA (9) | 21.89 | Sell |
| ADX (14) | 9.14 | Neutral |
| ATR (14) | 0.66 | Info |
The near term technical picture is bullish with a neutral RSI14 reading of 50 alongside a bullish overall sentiment. The price sits above the SMA50 of $20.58, while trading below the SMA200 at $22.95.
Key support is at $18.76 and resistance at $23.81, providing defined intra-range boundaries. The 30-day range shows activity from $17.02 to $27.52, highlighting recent volatility within a roughly $10 band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $17.87 | $21.00 | $31.06 | 0% | Neutral | |
| $18.15 | $24.04 | $34.20 | +14% | Neutral | |
| $23.52 | $32.52 | $48.61 | +55% | Bullish | |
| $27.61 | $39.59 | $61.52 | +89% | Bullish | |
| $25.41 | $37.64 | $60.44 | +79% | Bullish | |
| $26.84 | $40.98 | $67.69 | +95% | Bullish | |
| $27.43 | $43.09 | $72.99 | +105% | Bullish | |
| $26.33 | $42.52 | $73.68 | +102% | Bullish | |
| $30.75 | $50.96 | $90.16 | +143% | Bullish | |
| $35.19 | $59.82 | $107.91 | +185% | Bullish | |
| $39.13 | $74.87 | $146.31 | +257% | Bullish | |
| $80.62 | $179.16 | $392.51 | +753% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $17.87 | $21.00 | $24.79 | +0.00% |
| June 2026 | $17.42 | $20.68 | $25.30 | -1.50% |
| July 2026 | $17.84 | $21.45 | $26.75 | +3.68% |
| August 2026 | $18.85 | $22.90 | $29.00 | +6.76% |
| September 2026 | $18.76 | $22.97 | $29.44 | +0.31% |
| October 2026 | $18.27 | $22.55 | $29.22 | -1.83% |
| November 2026 | $18.68 | $23.21 | $30.37 | +2.93% |
| December 2026 | $18.81 | $23.52 | $31.06 | +1.36% |
Click any year to see its month-by-month KMTS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect KMTS to range from $17.87 to $31.06 through 2026. The $21.00 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The KMTS price prediction for 2027 points to an average of $24.04 (low $18.15, high $34.20) — a potential gain of +14% on today's $21.00. A consolidation phase looks the most probable path here.
In 2028, KMTS is projected to trade between $23.52 and $48.61, averaging $32.52 — a potential gain of +55% from today's $21.00. That is up +35% on the projected 2027 average. Momentum favours further upside here.
Kestra Medical Technologies, Ltd.'s 2029 outlook centres on $39.59, within a $27.61 to $61.52 range. That is up +22% on the projected 2028 average. That marks a +89% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, KMTS could reach as high as $60.44, with a base case around $37.64 and support toward $25.41 — roughly +79% from $21.00. Momentum favours further upside here.
Expect KMTS to range from $26.84 to $67.69 through 2031. The $40.98 average target implies a +95% move from current prices. That is up +9% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The KMTS price prediction for 2032 points to an average of $43.09 (low $27.43, high $72.99) — a potential gain of +105% on today's $21.00. Momentum favours further upside here.
In 2033, KMTS is projected to trade between $26.33 and $73.68, averaging $42.52 — a potential gain of +102% from today's $21.00. That is -1% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
Kestra Medical Technologies, Ltd.'s 2034 outlook centres on $50.96, within a $30.75 to $90.16 range. That is up +20% on the projected 2033 average. That marks a +143% change versus current levels. Momentum favours further upside here.
By 2035, KMTS could reach as high as $107.91, with a base case around $59.82 and support toward $35.19 — roughly +185% from $21.00. Buyers look set to stay in control over this stretch.
Expect KMTS to range from $39.13 to $146.31 through 2040. The $74.87 average target implies a +257% move from current prices. That is up +25% on the projected 2035 average. Momentum favours further upside here.
The KMTS price prediction for 2050 points to an average of $179.16 (low $80.62, high $392.51) — a potential gain of +753% on today's $21.00. Buyers look set to stay in control over this stretch.
Investing $1,000 in KMTS today (≈ 47.619048 KMTS) could be worth
$8,531.43
+$7,531.43 (+753%) by 2050 · US Dollar
Based on the average projected KMTS price of $179.16 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KMTSwould be worth at today's price.
$1,000 invested in KMTS on May 27, 2025 (≈ 44.404972 KMTS) would be worth
$932.5
-$67.5 (-6.7%) today · 0.93× · US Dollar
Based on a KMTS entry price of $22.52 vs. today's $21.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $20.76 | $1,011.56 | +1.2% |
| 1 month ago | $22.23 | $944.67 | -5.5% |
| 3 months ago | $24.55 | $855.4 | -14.5% |
| 6 months ago | $26.98 | $778.35 | -22.2% |
| 1 year ago | $22.52 | $932.5 | -6.7% |
| All time (1.2y) ago | $21.84 | $961.54 | -3.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KMTS forecast.
Our base-case forecast reaches $42.00 around 2032.
Implied market cap at $42.00: $2.45B
The multi-year forecast shows a bullish trajectory after a neutral start in 2026. In 2027 the average price is projected at $25.53 with an ROI of 18 and neutral sentiment, followed by stronger gains in subsequent years. By 2028 the average rises to $35.45 (ROI 63.8) and 2029 to $42.88 (ROI 98.2), with ongoing bullish sentiment.
In 2030 the average is forecast at $40.68 (ROI 88), and by 2031–2032 the averages reach $45.13 and $47.42 respectively, continuing the bullish path. By 2034 the average is $57.84 (ROI 167.3) and by 2035 it is $67.81 (ROI 213.3). Looking further ahead, 2040 shows an average of $86.64 (ROI 300.4) and 2050 an average of $207.72 (ROI 859.9), with max values reaching $172.18 in 2040 and $464.00 in 2050.
These are estimates, not guarantees. The figures illustrate potential outcomes under varying conditions and should not be construed as financial advice.
Tap a question to reveal the answer.
The forecast shows an average price of $40.68, with a min of $27.12 and a max of $66.09, and an ROI of 88. The sentiment is bullish.
Forecasts indicate a bullish trajectory across later years, with 2030–2050 averages rising to $40.68, $86.64, and $207.72 respectively and ROIs up to 88, 300.4, and 859.9, while 2026 shows a neutral start with an average of $21.64 and ROI of 0.
Yes. The forecast max values exceed $100 in several years: $124.15 (2035), $172.18 (2040), and $464.00 (2050). The corresponding average prices for those years are $67.81 (2035), $86.64 (2040), and $207.72 (2050).
The 30-day range is $17.02 to $27.52.
The current price is $21.64 per share, and the market cap is $1.26B.
Kestra Medical Technologies, Ltd. Community Discussion
0Share your Kestra Medical Technologies, Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.